Voluntary Scheme for Branded Medicines Pricing and Access
(asked on 27th June 2023) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to support small businesses through the voluntary scheme for branded medicines pricing and access.
This question was answered on 3rd July 2023
The voluntary scheme for branded medicines pricing and access (VPAS) includes strong commercial incentives in the form of freedom of list pricing and exemptions from payments for medicines containing a new active substance. Smaller companies are specifically supported through payment exemptions for those with under £5 million sales and a taper for companies between £5 million and £25 million sales.